Hosts: Vincent Racaniello, Rich Condit, and Abbie Smith
Vincent, Rich, and Abbie review a broad spectrum antiviral protein, and selective pressure applied by a failed HIV-1 vaccine.
[powerpress url=”http://traffic.libsyn.com/twiv/TWiV146.mp3″]
Click the arrow above to play, or right-click to download TWiV 146 (78 MB .mp3, 107 minutes).
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, by email, or listen on your mobile device with the Microbeworld app.
Links for this episode:
- Broad spectrum antiviral (PLoS One)
- Selection by failed HIV-1 vaccine (Nature Medicine)
- HIV vaccine impacts virus (EurekAlert!)
- TWiV on Facebook
- Letters read on TWiV 146
Weekly Science Picks
Vincent – Hypothetical Risk: Cambridge City Council’s Hearings on Recombinant DNA Research
Rich – Z Corporation 3-D printer (YouTube)
Listener Pick of the Week
Jim – Do-it-yourself DNA extraction (Citizen Scientist Quarterly)
Send your virology questions and comments (email or mp3 file) to twiv@microbe.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twiv.
On the one side I’m very glad that someone started to develop a broad-spectrum antiviral but on the other side I’m really scared that if anything goes wrong with DRACOs they will induce apoptosis in too many cells and ultimately lead to the death of the patient.Â
Dr. Rider also holds the patent on anti-pathogen treatments:
http://www.google.com/patents?id=4GXIAAAAEBAJ&printsec=frontcover&dq=%22Todd+H+Rider%22&hl=en&ei=shNdTuejJtODtgexzLXUAw&sa=X&oi=book_result&ct=result&resnum=1&ved=0CCwQ6AEwAA
Hi guys, good talk – I really loved that DRACO paper. And, thanks for the shout out ruleof6ix!
Connor
nice theme. but it takes a while to load